N/A
Manufactured by Baxter Healthcare Corporation
2,155 FDA adverse event reports analyzed
Last updated: 2026-04-15
FLUMAZENIL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Baxter Healthcare Corporation. The most commonly reported adverse reactions for FLUMAZENIL include INTENTIONAL OVERDOSE, DRUG INEFFECTIVE, TOXICITY TO VARIOUS AGENTS, COMA, OFF LABEL USE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for FLUMAZENIL.
Out of 816 classified reports for FLUMAZENIL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.